TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24628789

Group type: EXPERIMENTAL
Intervention: AS03A-H5N1 booster vaccine given at Month 6
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: AS03A-H5N1 booster vaccine given at Month 12
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: AS03A-H5N1 booster vaccine given at Month 36
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: AS03A-H5N1 heterologous booster vaccination
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: AS03A-H5N1 booster vaccine
Number of subjects: 1206
Study: 22459310

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 9376

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 9376
Study: 20056923

Group type: EXPERIMENTAL
Intervention: Vascular care
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 123
Study: 17608677

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Epiphany
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pulp Canal Sealer (EWT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Endométhasone
Number of subjects: 64
Study: 16254583

Group type: EXPERIMENTAL
Intervention: Middle-aged French volunteers (aged 55-70 years)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Italian elderly volunteers (aged 70-85 years)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Middle-aged population
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Red blood cell zinc
Number of subjects: 387
Study: 12383572

Group type: EXPERIMENTAL
Intervention: Dobutamine (5 to 20 microg/kg/min intravenously)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Enoximone (0.5 to 2 mg/kg intravenously)
Number of subjects: 29
Study: 10420746

Group type: EXPERIMENTAL
Intervention: Ramipril (0.25-0.50 mg daily for 1.5-2 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (ramipril-untreated patients)
Number of subjects: 108
Study: 8976498

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine administration
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no nicotine)
Number of subjects: 4
Study: 1441879

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg orally approximately 100 min before anaesthesia and three times daily for the first 2 postoperative days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 48
Study: 3969351

Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No phototherapy (Control)
Number of subjects: 0
Study: 31571712

Group type: EXPERIMENTAL
Intervention: Sodium valproate 500 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propranolol SR 40 mg/day
Number of subjects: 60
Study: 29762864

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate‐umeclidinium‐vilanterol (100 μg/62.5 μg/25 μg; Ellipta inhaler)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Budesonide/formoterol (400 μg/12 μg; Turbuhaler)
Number of subjects: 74
Study: 26681720

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 4718

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4718

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 4718
Study: 25288624

Group type: EXPERIMENTAL
Intervention: Transtibial PCL reconstruction with hamstring autograft
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Tibial inlay PCL reconstruction with patellar tendon autograft
Number of subjects: 66
Study: 22251419

Group type: EXPERIMENTAL
Intervention: Lubiprostone 8 mcg, twice daily for 36 weeks
Number of subjects: 522
Study: 19926151

Group type: EXPERIMENTAL
Intervention: REFLECT statement for livestock and food safety
Number of subjects: 24

Group type: COMPARATOR
Intervention: CONSORT checklist
Number of subjects: 24
Study: 18062107

Group type: EXPERIMENTAL
Intervention: ABM/P-15 hydrogel
Number of subjects: 19

Group type: COMPARATOR
Intervention: ABM/P-15 particulate
Number of subjects: 19
Study: 16225718

Group type: EXPERIMENTAL
Intervention: Paramedian approach
Number of subjects: 30

Group type: COMPARATOR
Intervention: Midline approach
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 30
Study: 12107605

Group type: EXPERIMENTAL
Intervention: 200 microg BDP as four inhalations from 50 microg/actuation P&B
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 microg BDP as four inhalations from 50 microg/actuation AH
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 400 microg BDP as four inhalations from 100 microg/actuation AH
Number of subjects: 18

Group type: COMPARATOR
Intervention: P&B inhaler
Number of subjects: 18

Group type: COMPARATOR
Intervention: AH inhaler
Number of subjects: 18
Study: 10443601

Group type: EXPERIMENTAL
Intervention: 50 microg intrathecal clonidine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 100 microg intrathecal clonidine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 200 microg intrathecal clonidine
Number of subjects: 36
Study: 7494722

Group type: EXPERIMENTAL
Intervention: Structured treatment and teaching program for non-insulin-treated type II diabetic patients
Number of subjects: 0
Study: 1580072

Group type: EXPERIMENTAL
Intervention: Self-medication with antidiarrhoeal agents, analgesics/antipyretics, antibiotics, and oral contraceptives
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Self-medication with pyrimethamine/sulfadoxine
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Self-medication with mefloquine
Number of subjects: 193
Study: 6716222

Group type: EXPERIMENTAL
Intervention: Calcium given as a bolus
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Calcium given as a drip
Number of subjects: 27

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 27
Study: 30789417

Group type: EXPERIMENTAL
Intervention: FOB-Gold
Number of subjects: 42179

Group type: COMPARATOR
Intervention: OC-Sensor
Number of subjects: 42179
Study: 28913825

Group type: EXPERIMENTAL
Intervention: Combined nursing and medical approach
Number of subjects: 200

Group type: COMPARATOR
Intervention: Medical follow-up only (control group)
Number of subjects: 200
Study: 27225217

Group type: EXPERIMENTAL
Intervention: South Asian Heart Lifestyle Intervention
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Self-monitoring with pedometers
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Greater family involvement and women-only exercise classes
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Community-based delivery and cultural adaptation
Number of subjects: 63
Study: 24498853

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg orally
Number of subjects: 51
Study: 22875231

Group type: EXPERIMENTAL
Intervention: Walking after meals
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inactivity after meals
Number of subjects: 24
Study: 20345024

Group type: EXPERIMENTAL
Intervention: Oblique-pulling maneuver
Number of subjects: 65

Group type: COMPARATOR
Intervention: Lumbar traction therapy
Number of subjects: 65
Study: 17684661

Group type: EXPERIMENTAL
Intervention: Trazodone for 60 days
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo for 60 days
Number of subjects: 85
Study: 16236737

Group type: EXPERIMENTAL
Intervention: One year of trastuzumab treatment
Number of subjects: 5077

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 5077
Study: 12198006

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg, elemental form as acetate, twice daily for 6 days)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 85
Study: 10192202

Group type: EXPERIMENTAL
Intervention: Fecal elastase-1 determination
Number of subjects: 28

Group type: COMPARATOR
Intervention: Secretin-CCK test
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fecal fat excretion
Number of subjects: 28
Study: 8845088

Group type: EXPERIMENTAL
Intervention: Trandolapril (2 mg once daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 2127690

Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy (CAF followed by PH)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Alternating chemotherapy (CAF/PH)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Both regimens (CAF greater than PH and CAF/PH)
Number of subjects: 301
Study: 30856

Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 31536746

Group type: EXPERIMENTAL
Intervention: Collagen dressing material
Number of subjects: 30

Group type: COMPARATOR
Intervention: Foam dressing alone (control group)
Number of subjects: 30
Study: 27754808

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg) daily for 1 to 6 menstrual cycles
Number of subjects: 1214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1214
Study: 25466493

Group type: EXPERIMENTAL
Intervention: Circuit Weight Training (CWT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training (AET)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 59
Study: 23398222

Group type: EXPERIMENTAL
Intervention: Psychosocial treatment in addition to treatment-as-usual
Number of subjects: 78
Study: 21117970

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus Fenofibrate 160 mg
Number of subjects: 625

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 625
Study: 19260251

Group type: EXPERIMENTAL
Intervention: 5 grams of capsicum
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16717336

Group type: EXPERIMENTAL
Intervention: 1% lidocaine (group P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1% lidocaine derived from 2% lidocaine diluted with saline (group D)
Number of subjects: 40
Study: 15549367

Group type: EXPERIMENTAL
Intervention: Exercise testing on a treadmill until maximal oxygen consumption was achieved.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Resting systolic blood pressure difference greater than 2.67 kPa (20 mmHg).
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Exercise testing.
Number of subjects: 41
Study: 11585001

Group type: EXPERIMENTAL
Intervention: Dalteparin sodium
Number of subjects: 0
Study: 9218745

Group type: EXPERIMENTAL
Intervention: Low-fat high-carbohydrate diet (intensive individual counselling to reduce total dietary fat to 15% of calories)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (general advice about diet without counselling to change fat intake)
Number of subjects: 220
Study: 8483989

Group type: EXPERIMENTAL
Intervention: Gliclazide (40 mg twice daily)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Healthy living (diet and exercise)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 3318424

Group type: EXPERIMENTAL
Intervention: Nabumetone 1,000 mg at bedtime
Number of subjects: 37

Group type: COMPARATOR
Intervention: Naproxen 250 mg twice daily
Number of subjects: 37
Study: 31167195

Group type: EXPERIMENTAL
Intervention: Fetal surgery for SB
Number of subjects: 20
Study: 29617196

Group type: EXPERIMENTAL
Intervention: Advertisements for healthy foods from perceivably healthy restaurant brands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brand commitment and health consciousness
Number of subjects: 0
Study: 27008432

Group type: EXPERIMENTAL
Intervention: Peer Assisted Learning (PAL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no PAL)
Number of subjects: 50
Study: 25652686

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 57
Study: 24358141

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Dynamic compression plate (DCP)
Number of subjects: 448
Study: 20433766

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (special developed carton style nutrition education handbook)
Number of subjects: 9750

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (Happy 10 program)
Number of subjects: 9750

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention strategy
Number of subjects: 9750

Group type: COMPARATOR
Intervention: Nutrition education only
Number of subjects: 9750

Group type: COMPARATOR
Intervention: Physical activity only
Number of subjects: 9750
Study: 18657828

Group type: EXPERIMENTAL
Intervention: Preterm formula (PF)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Term formula (TF)
Number of subjects: 49
Study: 16316811

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg two to three times per day)
Number of subjects: 116
Study: 12904324

Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acid (PUFA) diet (fish oil capsules containing 3.2 g eicosapentaenoic acid and 2.2 g docohexaenoic acid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo diet (olive oil capsules)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA diet
Number of subjects: 20
Study: 10370739

Group type: EXPERIMENTAL
Intervention: Lung resection surgery
Number of subjects: 36

Group type: COMPARATOR
Intervention: Thoracotomy for other reasons (Control)
Number of subjects: 36
Study: 8900981

Group type: EXPERIMENTAL
Intervention: Isotonic exercise (ITE)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise (IKE)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No exercise (NOE)
Number of subjects: 19
Study: 2049249

Group type: EXPERIMENTAL
Intervention: Quinine 5 mg kg‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Quinine 10 mg kg‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Quinine 15 mg kg‐1
Number of subjects: 6
Study: 6836710

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 6
Study: 31062046

Group type: EXPERIMENTAL
Intervention: Ulimorelin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 120
Study: 28654669

Group type: EXPERIMENTAL
Intervention: Magnesium chloride (248 mg of elemental magnesium per day) for 6 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control (no treatment) for 6 weeks
Number of subjects: 126
Study: 26806542

Group type: EXPERIMENTAL
Intervention: 3 Hz mobilisation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 Hz mobilisation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo (sustained static pressure to L4 vertebra)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no contact)
Number of subjects: 60
Study: 25088287

Group type: EXPERIMENTAL
Intervention: Lifetime bipolar disorders and atypical depression
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Substance use disorders (SUD) in men
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Lifetime combined depression
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Lifetime unspecified depression
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Current combined depression
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Current unspecified depression
Number of subjects: 3719
Study: 21847611

Group type: EXPERIMENTAL
Intervention: High-low: 3.2 g BA/day for 4 weeks, followed by 1.6 g BA/day for 4 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low-low: 1.6 g BA/day for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19684100

Group type: EXPERIMENTAL
Intervention: Postnatal home visit on day one
Number of subjects: 9211

Group type: EXPERIMENTAL
Intervention: Postnatal home visit on day two
Number of subjects: 9211

Group type: COMPARATOR
Intervention: Postnatal home visit after day two
Number of subjects: 9211
Study: 19589793

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA) of atrial fibrillation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Electrophysiology study (EPS)
Number of subjects: 56
Study: 15629816

Group type: EXPERIMENTAL
Intervention: Mean angle width
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Clock hours of PAS
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Untreated IOP
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Vertical cup-to-disc ratio
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Baseline untreated IOP
Number of subjects: 275
Study: 12133155

Group type: COMPARATOR
Intervention: Attending physician only
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Attending physician plus medical student
Number of subjects: 134
Study: 10372875

Group type: EXPERIMENTAL
Intervention: 12.0 mm lens
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 12.5 mm lens
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 13.0 mm lens
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 13.5 mm lens
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of 12.0 mm and 13.5 mm lenses
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of lens diameter and comfort
Number of subjects: 23
Study: 7547157

Group type: EXPERIMENTAL
Intervention: Loperamide oxide 1 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loperamide oxide 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loperamide 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2206069

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (up to 3 gm/hr)
Number of subjects: 156

Group type: COMPARATOR
Intervention: No tocolytic therapy (control)
Number of subjects: 156
Study: 6767944

Group type: EXPERIMENTAL
Intervention: bezafibrate (3 x 200 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: discontinuation of bezafibrate
Number of subjects: 25
Study: 31928611

Group type: COMPARATOR
Intervention: Conventional with best-practice prevention (local anaesthetic, carious tissue removal, filling placement)
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Biological with best-practice prevention (sealing-in decay, selective carious tissue removal and fissure sealants)
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Best-practice prevention alone (dietary and toothbrushing advice, topical fluoride and fissure sealing of permanent teeth)
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Biological arm vs Conventional arm
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Prevention alone arm vs Conventional arm
Number of subjects: 1144
Study: 28922935

Group type: EXPERIMENTAL
Intervention: Explicit stereotype threat (ST) priming
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Moderate to high levels of trait perseveration
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no ST priming)
Number of subjects: 43
Study: 28003500

Group type: EXPERIMENTAL
Intervention: Intensive medical management of risk factors
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Higher physical activity levels
Number of subjects: 227

Group type: COMPARATOR
Intervention: Out of target for systolic blood pressure and physical activity, higher mean low-density lipoprotein cholesterol and non-high-density lipoprotein
Number of subjects: 227
Study: 24566991

Group type: EXPERIMENTAL
Intervention: Twice-a-week supervised aerobic and resistance training plus exercise counseling (EXE)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Counseling alone (CON)
Number of subjects: 606
Study: 22657950

Group type: EXPERIMENTAL
Intervention: AXOS-enriched breads (2.2 g AXOS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control breads (non-endoxylanase treated)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo breads
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AXOS-enriched breads
Number of subjects: 40
Study: 19947803

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (57 patients)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard of care (47 patients)
Number of subjects: 104
Study: 17697451

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (100 microg/kg or a fixed dose of 6 mg)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Filgrastim (5 microg/kg/day)
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Number of subjects: 617
Study: 15103534

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) delivered by trained social workers
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine care from social workers (Control)
Number of subjects: 52
Study: 11153777

Group type: EXPERIMENTAL
Intervention: PET-guided management (n=49; 12 PTCA, 14 CABG, 23 drug therapy)
Number of subjects: 103

Group type: COMPARATOR
Intervention: SPECT-guided management (n=54; 15 PTCA, 13 CABG, 26 drug therapy)
Number of subjects: 103
Study: 9663912

Group type: EXPERIMENTAL
Intervention: Lisinopril treatment after 3 and 12 months
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Lisinopril plus hydrochlorothiazide treatment after 3 and 12 months
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo treatment after a final 4-week period
Number of subjects: 170
Study: 7811826

Group type: COMPARATOR
Intervention: Lactulose hydrogen breath test
Number of subjects: 61
Study: 2839321

Group type: EXPERIMENTAL
Intervention: Methylcellulose 4 g
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Methylcellulose 1 g, 2 g, or 4 g
Number of subjects: 109

Group type: COMPARATOR
Intervention: Psyllium 3.4 g
Number of subjects: 109
Study: 16303008

Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (SRL) with low-dose MMF
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-dose cyclosporine (CsA) with low-dose MMF
Number of subjects: 21
Study: 31284842

Group type: EXPERIMENTAL
Intervention: PrEP services offered at FQHCs
Number of subjects: 360

Group type: COMPARATOR
Intervention: PrEP services in southern metropolitan areas
Number of subjects: 360

Group type: COMPARATOR
Intervention: PrEP services in non-southern metropolitan areas
Number of subjects: 360

Group type: COMPARATOR
Intervention: Comparison of PrEP availability by region
Number of subjects: 360

Group type: COMPARATOR
Intervention: Total number of FQHCs in southern metropolitan areas
Number of subjects: 360